Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

National Institute Of Dental And Craniofacial Research (nidcr)

Clinical trials sponsored by National Institute Of Dental And Craniofacial Research (nidcr), explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Cactus extract could zap cancer pain in new trial Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 10 Not yet finished but already full! 1 Completed 5 Terminated 1

Could a common arthritis drug tame Sjogren's syndrome?

Disease control Ongoing

This early-phase trial is testing the safety of tofacitinib (Xeljanz), a drug already used for rheumatoid arthritis, in 23 adults with mild-to-moderate Sjogren's syndrome. Participants take the drug or a placebo daily for 168 days. The goal is to see if the drug is safe and toler…

Phase 1/2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC